Trial
NCT02446886
Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
Mallinckrodt
Condition
Multiple Sclerosis
Intervention
Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-22